New patent for Glaxosmithkline drug TRELEGY ELLIPTA

October 13, 2020 Comments Off Posted in: Patent Added

Annual Drug Patent Expirations for TRELEGY+ELLIPTA Trelegy Ellipta is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from one supplier. There are nineteen patents…

The post New patent for Glaxosmithkline drug TRELEGY ELLIPTA appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.